Xilio Therapeutics | 8-K: Xilio Therapeutics Announces Pipeline and Business Updates and Second Quarter 2024 Financial Results
Xilio Therapeutics | 8-K: Current report
Xilio Therapeutics | 8-K: Current report
Xilio Therapeutics | 8-K: Xilio Therapeutics Announces Pipeline and Business Updates and First Quarter 2024 Financial Results
Xilio Therapeutics | S-3: Registration statement for specified transactions by certain issuers
Xilio Therapeutics | DEFA14A: Others
Xilio Therapeutics | DEF 14A: Definitive information statements
Xilio Therapeutics | S-8: Initial registration statement for securities to be offered to employees pursuant to employee benefit plans
Xilio Therapeutics | 8-K: Xilio Therapeutics Announces Pipeline and Business Updates and Fourth Quarter and Full Year 2023 Financial Results
Xilio Therapeutics | 8-K: Current report
Xilio Therapeutics | 8-K: Current report
Xilio Therapeutics | 8-K: Current report
Xilio Therapeutics | 8-K: Current report
Xilio Therapeutics | 8-K: Current report
Xilio Therapeutics | 8-K: Xilio Therapeutics Announces Pipeline and Business Updates and Third Quarter 2023 Financial Results
Xilio Therapeutics | 8-K: Current report
Xilio Therapeutics | 8-K: Current report
Xilio Therapeutics | 8-K: Xilio Therapeutics Announces Pipeline and Business Updates and Second Quarter 2023 Financial Results
Xilio Therapeutics | 8-K: Current report
Xilio Therapeutics | 8-K: Current report
No Data